Context
The pharmaceutical sector is at a decisive crossroads. Rapidly evolving European regulation, rising innovation costs, and increasing public scrutiny are reshaping how companies operate and lead. At the same time, the next generation of professionals is searching for clarity, purpose, and credible leadership in healthcare and life sciences. Belgium, as a strategic hub for Johnson & Johnson in Europe, sits at the heart of many of these developments.
Guiding Questions
■ What does it take to survive — and lead — in today’s pharmaceutical industry?
■ How is Europe’s legislative environment shaping long-term strategy, investment, and competitiveness?
■ How can complex policy, operational, and business realities be made tangible for young professionals entering the sector?
Confirmed Speakers
■ Tom Aelbrecht — COO, J&J Campus Belgium & Head of Strategy
■ Katrien Lindemans — Business Unit Director Surgery BeLux, J&J MedTech
■ Norma Montes — Senior Director, Technical Operations & Risk Functions
Format
The evening combines a moderated panel discussion with leaders between speakers and participants. A networking reception will conclude the session.
Venue
The roundtable will take place at the University Foundation (Club Universitaire), a historic venue in the heart of Brussels and a long-standing meeting point for European academic and policy communities.
Target Audience
All welcome.